JP2023546561A5 - - Google Patents
Info
- Publication number
- JP2023546561A5 JP2023546561A5 JP2023521735A JP2023521735A JP2023546561A5 JP 2023546561 A5 JP2023546561 A5 JP 2023546561A5 JP 2023521735 A JP2023521735 A JP 2023521735A JP 2023521735 A JP2023521735 A JP 2023521735A JP 2023546561 A5 JP2023546561 A5 JP 2023546561A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- binds
- protein
- chimera
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063091769P | 2020-10-14 | 2020-10-14 | |
| US63/091,769 | 2020-10-14 | ||
| PCT/US2021/054954 WO2022081827A1 (en) | 2020-10-14 | 2021-10-14 | Chimeric conjugates for degradation of viral and host proteins and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023546561A JP2023546561A (ja) | 2023-11-06 |
| JP2023546561A5 true JP2023546561A5 (cg-RX-API-DMAC10.html) | 2024-10-22 |
Family
ID=78709532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521735A Pending JP2023546561A (ja) | 2020-10-14 | 2021-10-14 | ウイルスタンパク質および宿主タンパク質の分解のためのキメラコンジュゲートならびに使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230330238A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4228699A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2023546561A (cg-RX-API-DMAC10.html) |
| CN (1) | CN116801908A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2021360898A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3193261A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022081827A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024003300A1 (en) * | 2022-06-30 | 2024-01-04 | Aptadegrad, S.L. | Dna aptamer conjugates recognizing and degrading coronavirus proteins |
| GB202214796D0 (en) | 2022-10-07 | 2022-11-23 | Tocris Cookson Ltd | Compounds |
| GB202214800D0 (en) | 2022-10-07 | 2022-11-23 | Tocris Cookson Ltd | Compounds |
| WO2024086132A1 (en) * | 2022-10-17 | 2024-04-25 | Ohio University | Protacs targeting viral enzymes for precise treatment of covid-19 |
| CN121889401A (zh) * | 2023-10-04 | 2026-04-17 | 丹娜-法伯癌症研究院 | 使用靶向蛋白质降解剂对mdm2扩增癌症进行选择性抑制 |
| WO2025245225A1 (en) * | 2024-05-22 | 2025-11-27 | Dana-Farber Cancer Institute, Inc. | Stapled peptide proteolysis targeting chimeras (sp-protacs) and methods of use |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5446090A (en) | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
| US20020064546A1 (en) | 1996-09-13 | 2002-05-30 | J. Milton Harris | Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor |
| ES2211033T3 (es) | 1998-01-07 | 2004-07-01 | Debio Recherche Pharmaceutique S.A. | Acrilatos de polietilenglicol heterobifuncionales degradables y geles y conjugados derivados de dichos acrilatos. |
| US7192713B1 (en) | 1999-05-18 | 2007-03-20 | President And Fellows Of Harvard College | Stabilized compounds having secondary structure motifs |
| US6348558B1 (en) | 1999-12-10 | 2002-02-19 | Shearwater Corporation | Hydrolytically degradable polymers and hydrogels made therefrom |
| BR0001870B1 (pt) | 2000-05-29 | 2014-02-25 | Peptídeo, processo de obtenção de peptídeo, formulação compreendendo peptídeo, método de prevenção de crescimento de parasitas, fungos e bactérias, método para inativar a endotoxina de bactérias gram-negativas | |
| CN1187449C (zh) * | 2003-06-05 | 2005-02-02 | 中国科学院上海药物研究所 | 可溶性sars病毒3cl蛋白酶的表达和纯化 |
| EP1680443B9 (en) | 2003-11-05 | 2014-09-03 | Dana-Farber Cancer Institute, Inc. | Stabilized alpha helical peptides and uses thereof |
| US8889632B2 (en) | 2007-01-31 | 2014-11-18 | Dana-Farber Cancer Institute, Inc. | Stabilized p53 peptides and uses thereof |
| WO2008106507A2 (en) | 2007-02-27 | 2008-09-04 | University Of South Florida | Mdm2/mdmx inhibitor peptide |
| EP2508531B1 (en) | 2007-03-28 | 2016-10-19 | President and Fellows of Harvard College | Stitched polypeptides |
| EP2208061B1 (en) | 2007-09-26 | 2017-11-08 | Dana Farber Cancer Institute | Methods and compositions for modulating bcl-2 family polypeptides |
| JP5788178B2 (ja) * | 2008-01-23 | 2015-09-30 | ダナ ファーバー キャンサー インスティテュート インコーポレイテッド | ウィルス感染症の治療のための組成物及び方法 |
| US8586707B2 (en) | 2008-09-16 | 2013-11-19 | The Research Foundation Of State University Of New York | Stapled peptides and method of synthesis |
| US8524653B2 (en) | 2008-09-22 | 2013-09-03 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| WO2010060112A1 (en) | 2008-11-24 | 2010-05-27 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles with improved properties |
| EP3549951A3 (en) | 2008-12-09 | 2019-11-20 | Dana Farber Cancer Institute, Inc. | Methods and compositions for specific modulation of mcl-1 |
| EP3698811A1 (en) | 2009-06-18 | 2020-08-26 | Dana Farber Cancer Institute, Inc. | Structured viral peptide compositions and methods of use |
| WO2011008260A2 (en) | 2009-07-13 | 2011-01-20 | President And Fellows Of Harvard College | Bifunctional stapled polypeptides and uses thereof |
| US9297017B2 (en) | 2010-06-08 | 2016-03-29 | University Of Washington | Methods and compositions for targeted protein degradation |
| AU2011314335A1 (en) * | 2010-06-25 | 2013-01-31 | Purdue Research Foundation | Pathogen detection |
| EP2637680B1 (en) | 2010-11-12 | 2017-03-01 | Dana-Farber Cancer Institute, Inc. | Cancer therapies |
| SG10201601840RA (en) | 2011-09-09 | 2016-04-28 | Agency Science Tech & Res | P53 activating peptides |
| US9408885B2 (en) | 2011-12-01 | 2016-08-09 | Vib Vzw | Combinations of therapeutic agents for treating melanoma |
| KR102112373B1 (ko) | 2012-02-15 | 2020-05-18 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티드모방체 마크로사이클 |
| CA3113959A1 (en) | 2012-09-26 | 2014-04-03 | President And Fellows Of Harvard College | Proline-locked stapled peptides and uses thereof |
| WO2014055039A1 (en) | 2012-10-01 | 2014-04-10 | Agency For Science, Technology And Research | Peptides and methods for treating cancer |
| KR101616603B1 (ko) | 2012-10-11 | 2016-04-28 | 서울대학교산학협력단 | 메틸 데그론 펩타이드 및 이를 이용한 단백질 수명 조절 방법 |
| WO2014065760A1 (en) | 2012-10-25 | 2014-05-01 | Agency For Science, Technology And Research | Methods for determining resistance against molecules targeting proteins |
| EP2912463A4 (en) | 2012-10-25 | 2016-03-23 | Agency Science Tech & Res | PROCESS FOR DETERMINING THE RESISTANCE TO MOLECULES FOR THE TARGETING OF PROTEINS |
| US9115184B2 (en) | 2013-03-01 | 2015-08-25 | The Board Of Trustees Of The Leland Stanford Junior University | Light-inducible system for regulating protein stability |
| JP2018503595A (ja) * | 2014-09-24 | 2018-02-08 | エルロン・セラピューティクス・インコーポレイテッドAileron Therapeutics,Inc. | ペプチド模倣大環状分子およびその製剤 |
| SG11201706562QA (en) | 2015-02-13 | 2017-09-28 | Agency Science Tech & Res | NON-MEMBRANE DISRUPTIVE p53 ACTIVATING STAPLED PEPTIDES |
| US20190076504A1 (en) | 2016-03-23 | 2019-03-14 | Dana-Farber Cancer Institute, Inc. | COMPOSITIONS, ASSAYS, AND METHODS FOR TARGETING HDM2 AND HDMX TO REVERSE THE INHIBITION OF p53 IN PEDIATRIC CANCERS |
| WO2019133179A2 (en) * | 2017-12-01 | 2019-07-04 | Massachusetts Institute Of Technology | Solution-phase affinity selection of inhibitors from combinatorial peptide libraries |
| CN120118207A (zh) | 2017-12-15 | 2025-06-10 | 丹娜-法伯癌症研究院有限公司 | 稳定肽-介导的靶向蛋白降解 |
| US11707452B2 (en) * | 2018-08-20 | 2023-07-25 | Arvinas Operations, Inc. | Modulators of alpha-synuclein proteolysis and associated methods of use |
| CN110257357A (zh) * | 2019-07-04 | 2019-09-20 | 中国人民解放军军事科学院军事医学研究院 | MERS-CoV 3CLpro作为去泛素化酶和干扰素抑制剂的用途 |
-
2021
- 2021-10-14 WO PCT/US2021/054954 patent/WO2022081827A1/en not_active Ceased
- 2021-10-14 US US18/030,433 patent/US20230330238A1/en active Pending
- 2021-10-14 EP EP21811174.8A patent/EP4228699A1/en active Pending
- 2021-10-14 CA CA3193261A patent/CA3193261A1/en active Pending
- 2021-10-14 CN CN202180070311.3A patent/CN116801908A/zh active Pending
- 2021-10-14 JP JP2023521735A patent/JP2023546561A/ja active Pending
- 2021-10-14 AU AU2021360898A patent/AU2021360898A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nelissen et al. | Gelatinase B/matrix metalloproteinase‐9 cleaves interferon‐β and is a target for immunotherapy | |
| KR101873773B1 (ko) | 류마티즘 관절염 예방 또는 치료 조성물 | |
| Schellekens | Factors influencing the immunogenicity of therapeutic proteins | |
| RU2355700C9 (ru) | Новые пептиды как ингибиторы ns3-серинпротеазы вируса гепатита с | |
| Zawacka‐Pankau et al. | Pharmacological reactivation of p53 as a strategy to treat cancer | |
| BR0112666A (pt) | Peptìdeos como inibidores de ns3-serina protease de vìrus da hepatite c | |
| DE69334266D1 (de) | Therapeutische Zusammensetzungen aus Antikorper und Antisens Nukleinsäuren gegen Serrate | |
| JP2021506814A5 (cg-RX-API-DMAC10.html) | ||
| RU95115239A (ru) | Аналог эритропоэтина | |
| EP1322338A4 (en) | COMPOSITIONS AND METHODS FOR USE OF THE CAPSID PROTEIN FROM FLAVIVIRES OR PESTVIRUSES | |
| HUP0003384A2 (hu) | Legalább egy, kettős szálú RNS és legalább egy, vírus elleni szer kombinációját tartalmazó termék | |
| WO2002008256A3 (en) | Peptides as ns3-serine protease inhibitors of hepatitis c virus | |
| BR0212897A (pt) | Conjugados de análogos de somatostatina ou bombesina diagnóstica ou terapêutica e usos dos mesmos | |
| BRPI0307276B8 (pt) | uso de um peptídio para prevenção e/ou tratamento de esclerose múltipla | |
| JP2006506942A5 (cg-RX-API-DMAC10.html) | ||
| US20230330238A1 (en) | Chimeric conjugates for degradation of viral and host proteins and methods of use | |
| JP2023542453A5 (cg-RX-API-DMAC10.html) | ||
| KR20230008867A (ko) | 백신 항원으로서의 코로나바이러스 스파이크 단백질의 조작, 이의 설계 및 용도 | |
| DK0661999T3 (da) | Vacciner mod felint immundefekt virus (FIV) | |
| ES2171086T3 (es) | Uso de proteinas hmg para la preparacion de medicamentos con actividad citotoxica. | |
| KR20090016671A (ko) | 레플리킨 펩티드 및 이의 용도 | |
| KR970701724A (ko) | 스타니어스 단백질인 스타니오칼신의 소체(Corpuscles of stannius protein, stanniocalcin) | |
| CA2354153A1 (en) | Compounds and methods for modulating activation of nf-.kappa.b | |
| Minagar et al. | Efficacy and tolerability of intramuscular interferon beta-1a compared with subcutaneous interferon beta-1a in relapsing MS: results from PROOF | |
| EP2196211A1 (en) | Apolactoferrin compositions and methods of the use thereof for treating viral hepatitis c |